Medical imaging artificial intelligence company Viz said today it closed a $7.5 million seed round of financing to support the development of its AI platform.
Viz is developing an AI-equipped medical imaging platform with an initial focus on stroke, looking to improve outcomes and treatment of stroke patients by shortening the time between seeking and receiving treatment.
The company’s AI platform is being developed to compare patient scans to thousands of other scans to determine patterns within them, and aid in treatment accuracy and speed.
“As doctors, there is nothing more important to us than improving patient care and patient outcomes. Applying deep learning technology to create a diagnostic aide for doctors so they can provide a timely diagnosis for every patient can help doctors save more lives. When you bring the average standard of care closer to the best standard of care, everyone wins. Viz is like having the best radiologist in the world on your team, a teammate who never gets tired, takes a vacation or stops learning,” co-founder & CEO Chris Mansi said in a press release.
The round was led by DHVC and Innovation Endeavors and joined by AME Cloud Ventures, the San Francisco, Calif.-based company said.
“We invest in innovators using data to transform industries, and we expect Viz to revolutionize healthcare. No doctor wants to miss a diagnosis; Viz helps provide an unmatched level of diagnostic accuracy so doctors can quickly get patients to the right specialist. Led by a seasoned team of clinicians and technologists, Viz applies advanced artificial intelligence to dramatically reduce diagnostic errors and improve patient care,” Yahoo co-founder & AME Cloud Ventures founding partner Jerry Yang said in a prepared statement.
“Advances in computer science, and particularly machine learning, allow us to rethink conventional medical practice. The talented team at Viz is helping doctors to solve real clinical issues—like stroke. Over the next 10 years, the entire healthcare sector will benefit from the speed and accuracy that these technological advances afford,” Innovation Endeavors managing partner Dror Berman said in prepared remarks.
“Viz was an ideal investment given our focus on disruptive artificial intelligence and big data technologies. The potential power of artificial intelligence in medicine is undeniable. Viz is driving a new era of artificial intelligence in the healthcare arena that can reduce the time it takes for doctors to diagnose and treat patients—improving patient care and outcomes,” DHVC managing director Kevin Ding said in a prepared release.
